Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00351858
Status:
TERMINATED
Last Update Posted:
2015-05-01
First Post:
2006-07-12
Brief Title:
Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
Sponsor:
Neovii Biotech
Organization:
Neovii Biotech
Organization Data
Organization:
Neovii Biotech
Class:
INDUSTRY
Study ID:
FBT-IVREXBC 02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Neovii Biotech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None